Loading the company…
Loading the company…
㈜세레코
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-10-11 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Daejeon, founded in 2014. Industry: Cosmetics (K-Beauty). Revenue for 2025 was ₩5.9bn. It has 33 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Qualified”.
Loading…
Latest filing 2017-01-25 · latest registration 2019-05-21 · newest first
본 발명의 수크랄페이트의 용해 방법, 수크랄페이트를 포함하는 액상 화장료 및 그 제조방법은, 증류수에 수트랄페이트 분말 및 염화이온 함유 염을 첨가하고 분산시켜 분산용액을 제조하는 제1단계; 및 상기 분산용액에 구연산을 첨가하여 투명용액을 제조하는 제2단계;를 포함하여 이루어진다.
본 발명은 항염성 화장료 조성물에 관한 것으로서, 애엽 발효 추출물이 캡슐화된 나노리포좀을 유효 성분으로 포함함으로써, 천연 애엽의 염증 개선 효능을 극대화시키고, 경피흡수율을 현저히 증가시킨 항염성 화장료 조성물에 관한 것이다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 2 of 2 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 22.6 | 5.9 |
| Cost of sales | 15.9 | 6.5 |
| Gross profit (loss) | 6.7 | (0.6) |
| Selling, general and administrative expenses | 1.4 | 1.7 |
| Operating income (loss) | 5.3 | (2.3) |
| Non-operating income | 0.1 | 0.2 |
| Other gains | 0.0 | 0.1 |
| Finance income | 0.1 | 0.1 |
| Other | — | 0.0 |
| Non-operating expenses | 0.3 | 0.3 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.2 | 0.3 |
| Other | 0.1 | 0.0 |
| Profit (loss) before tax | 5.1 | (2.4) |
| Income tax expense | 0.8 | — |
| Net income (loss) | 4.3 | (2.4) |
Revenue ₩5.9bn, down 73.9% YoY.
Operating margin -39.2% (prior 23.4%).
Net income ₩-2.4bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-08